Assessment of Drugs Approved by Public Knowledge‐Based Applications ( Kouchi‐shinsei ) During the Last Two Decades in Japan

Author:

Maeda Hideki1,Fukuda Yuka1,Uchida Marika1

Affiliation:

1. Department of Regulatory Science Faculty of Pharmacy Meiji Pharmaceutical University Tokyo Japan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference48 articles.

1. Approval of New Drugs in the United States

2. Status of off‐label use of drug and its regulations in the US and Japan since late 1990s;Fukuzawa M.;Pharm. Med. Dev. Regul. Sci.,2011

3. Systematic Review: Reliability of Compendia Methods for Off-Label Oncology Indications

4. Ministry of Health and Welfare Japan.Handling of prescription drugs in insurance medical care (in Japanese) (1980). Accessed March 14 2021.

5. Pharmaceuticals and Medical Devices Agency Japan.Prescription drugs for reimbursement by health insurance coverage after review of pre‐evaluation on public knowledge‐based applications by Pharmaceutical Affairs and Food Sanitation Council during non‐approved period in Japan (in Japanese). Accessed March 14 2021.

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3